DI RESTA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.754
EU - Europa 2.562
AS - Asia 2.154
SA - Sud America 425
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 53
OC - Oceania 1
Totale 8.116
Nazione #
US - Stati Uniti d'America 2.650
RU - Federazione Russa 1.404
SG - Singapore 815
CN - Cina 645
IT - Italia 458
BR - Brasile 359
SE - Svezia 236
VN - Vietnam 222
HK - Hong Kong 214
DE - Germania 89
FR - Francia 83
GB - Regno Unito 71
BD - Bangladesh 59
FI - Finlandia 49
IN - India 49
CA - Canada 45
NL - Olanda 41
JP - Giappone 29
MX - Messico 28
ID - Indonesia 25
PL - Polonia 25
AR - Argentina 24
AT - Austria 21
ZA - Sudafrica 21
ES - Italia 20
IQ - Iraq 16
TR - Turchia 16
IE - Irlanda 15
EC - Ecuador 12
JM - Giamaica 10
PK - Pakistan 9
CL - Cile 8
CO - Colombia 8
GR - Grecia 8
LT - Lituania 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
PE - Perù 6
UA - Ucraina 6
BE - Belgio 5
CR - Costa Rica 5
MA - Marocco 5
PH - Filippine 5
SA - Arabia Saudita 5
LU - Lussemburgo 4
NG - Nigeria 4
PY - Paraguay 4
AZ - Azerbaigian 3
CM - Camerun 3
LV - Lettonia 3
MY - Malesia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UZ - Uzbekistan 3
A1 - Anonimo 2
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
SM - San Marino 2
SV - El Salvador 2
UY - Uruguay 2
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
Totale 7.948
Città #
Dallas 705
Singapore 427
Ashburn 330
Moscow 290
San Jose 249
Hong Kong 212
Shanghai 113
Milan 106
Council Bluffs 97
Beijing 93
New York 86
Hefei 80
Ho Chi Minh City 79
Lauterbourg 68
Lawrence 57
Princeton 57
Los Angeles 52
Hanoi 46
Orem 41
Phoenix 41
Rome 41
São Paulo 39
Helsinki 37
Santa Clara 35
Boardman 34
Tokyo 26
Denver 25
Warsaw 23
Seattle 19
Brooklyn 18
Amsterdam 17
Atlanta 17
Poplar 17
Montreal 16
Munich 16
Chicago 15
Dublin 15
Chennai 14
Houston 14
Stockholm 14
Johannesburg 12
Nuremberg 12
Cesano Boscone 11
Manchester 11
Mexico City 11
Rio de Janeiro 11
City of London 10
Da Nang 10
Frankfurt am Main 10
Lappeenranta 10
The Dalles 10
Belo Horizonte 9
Turin 9
Columbus 8
San Francisco 8
Bergamo 7
Boston 7
Brasília 7
Falkenstein 7
Guangzhou 7
Haiphong 7
Las Vegas 7
London 7
New Delhi 7
Philadelphia 7
Shenzhen 7
Verona 7
Washington 7
Ankara 6
Baghdad 6
Brescia 6
Buffalo 6
Curitiba 6
Hangzhou 6
Jakarta 6
Mumbai 6
Toronto 6
Vienna 6
Athens 5
Charlotte 5
Cuneo 5
Dhaka 5
Hải Dương 5
Kingston 5
Salvador 5
Santiago 5
Sorocaba 5
Tianjin 5
Trezzano sul Naviglio 5
Viareggio 5
Ardabil 4
Augusta 4
Biên Hòa 4
Bologna 4
Bắc Giang 4
Campinas 4
Cape Town 4
Cleveland 4
Concord 4
Esch-sur-Alzette 4
Totale 4.084
Nome #
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 450
Multidisciplinary Screening of a Novel Founder LMNA Mutation Associated With Cardiomyopathy in a Geographic Isolate 287
Heavy metals and human reproductive toxicity: Mechanisms, pregnancy outcomes, and mitigation strategies 175
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 173
Concealed Substrates in Brugada Syndrome: Isolated Channelopathy or Associated Cardiomyopathy? 168
Challenges of the Effectiveness of Traumatic Brain Injuries Biomarkers in the Sports-Related Context 164
Melanocortin-1 receptor (MC1R): a review for dermatologists 153
Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells 152
Machine Learning based on laboratory medicine test results in diagnosis and prognosis for COVID-19 patients: A systematic review 147
Electrocardiogram Changes in the Postictal Phase of Epileptic Seizure: Results from a Prospective Study 141
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 140
Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy 139
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 137
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests 136
Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation 126
Brugada syndrome genetics is associated with phenotype severity 126
The gender impact assessment among healthcare workers in the sars-cov-2 vaccination—an analysis of serological response and side effects 122
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy 120
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 118
Analytical Ancestry: Evolution of the Array in Analysis 115
A novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmia 115
Evidence of significant difference in key covid-19 biomarkers during the italian lockdown strategy. A retrospective study on patients admitted to a hospital emergency department in northern italy 112
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench 110
Health-related reference intervals for heavy metals in non-exposed young adults 109
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects 108
Current Updates on Expanded Carrier Screening: New Insights in the Omics Era 107
Exploratory assessment of serological tests to determine antibody titer against SARS-CoV-2: Appropriateness and limits 105
Molecular diagnostics in the prenatal age: technological evolution and ethical implications in reproductive medicine|La diagnostica molecolare in epoca prenatale: evoluzione tecnologica ed implicazioni etiche in medicina della riproduzione 104
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome 102
Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy 100
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 100
Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing 100
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 97
Cardiac magneti resonance and arrhythmic risk stratification of cardiomyopathy associated with lamin A/C mutations: results from a 5 years study 95
Links between accuracy and effectiveness of laboratory medicine equipment: use of the EUnetHTA core model to compare two analyzers by measuring HbA1c 92
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy 90
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 87
Effect of Carbamazepine and Related Compounds on Ligand-Gated Channels: Possible Implications for Synaptic Transmission and Side Effects. 86
Genetic background of mitral valve prolapse 86
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 85
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine 84
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 79
The total testing process harmonization: the case study of SARS-CoV-2 serological tests 78
Assessing the suitability of non-molecular methods for screening beta-thalassemia carriers: clinical insights from laboratory data 78
Exploiting the Whole Exome Sequencing for the identification of new candidate genes associated with Brugada Syndrome 77
Advance in Genomics of Rare Genetic Diseases 77
Alpha2-I279N human nicotinic acetylcholine receptors, linked to a form of nocturnal epilepsy, present higher sensitivity to agonists 77
Erratum: Genetic testing in neurology exploiting next generation sequencing: State of art (Neural Regeneration Research (2020) 15:2 (265-266) DOI: 10.4103/1673-5374.265554) 76
Editorial: Whole Genome Sequencing for rare diseases 75
Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear 74
Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches 70
Electrophysiological properties of mutant alpha2beta4 nAChR linked to a form of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) 68
High-throughput genetic characterization of a cohort of Brugada syndrome patients. 67
Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients 67
Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2 66
Generation of a triadin KnockOut syndrome zebrafish model 66
Premature cardiac senescence in patients with lamin A/C mutations: at least 5 years gap from electrical to mechanical dysfunction 65
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 65
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 63
Increased sensitivity of the alpha-2 neuronal nicotinic receptor causes familial epilepsy with nocturnal wandering and ictal fear 62
Genetics can contribute to the prognosis of the Brugada syndrome: a pilot model for risk stratification. 60
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign 60
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 59
Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study 59
Evaluation of damaging effects of splicing mutations: validation of an in vitro method for diagnostic laboratories 58
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 58
Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease 57
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 57
Translating genes into health. 55
Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities 55
Next Generation Sequencing: From Research Area to Clinical Practice 55
Increased sensitivity of the neuronal nicotinic receptor alpha2 subunit causes familial epilepsy with nocturnal wandering and ictal fear 54
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis 54
Personalized laboratory medicine: A patient-centered future approach 53
Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey 53
New molecular approaches to Alzheimer's disease 53
Implementation of companion diagnostics in the clinical laboratories: the BRAF example in Melanoma 52
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. 52
Human neuronal nicotinic receptors and epilepsy during sleep 51
Value-Based Health Care Implementation: The Case Study of mTBI Biomarkers 50
Genetic factors predisposing to bronchopulmonary dysplasia. A pilot study by exome sequencing and pathways analysis 50
P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study 50
Genetic testing in neurology exploiting next generation sequencing: State of art 50
Introduction to ion channels 48
Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old 46
Red Flags for Differentiating Desmosomal "Hot-Phase" Cardiomyopathy From Acute Myocarditis 28
Predictors of Disease Progression in Patients with Left Ventricular Nondilated Cardiomyopathy 18
null 4
Multimodal clinical phenotyping of CACNA1C p.(Arg518His) variant as a cause of cardiac-only Timothy syndrome 2
Diagnostic accuracy of blood biomarkers for excluding head CT abnormalities after mild traumatic brain injury in adults: a systematic review and meta-analysis 2
Totale 8.116
Categoria #
all - tutte 41.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202282 0 0 0 16 8 8 33 1 3 4 1 8
2022/2023434 133 85 37 0 14 57 13 29 16 2 25 23
2023/2024474 28 18 58 75 27 99 17 42 1 13 18 78
2024/20251.211 126 17 30 50 56 109 166 159 186 104 102 106
2025/20265.359 325 420 667 638 438 161 389 365 1.290 226 156 284
2026/2027504 150 250 104 0 0 0 0 0 0 0 0 0
Totale 8.116